Skip to main content
Log in

Dose–Response Relationship and Threshold Drug Dosage Identification for a Novel Hybrid Mechanical-Thrombolytic System with an Ultra-Low Dose Patch

  • Original Article
  • Published:
Cellular and Molecular Bioengineering Aims and scope Submit manuscript

Abstract

Introduction

Ischemic stroke treatment has advanced in the last two decades and intravenous thrombolysis is now considered the standard of care for selected patients. Recanalization can also be achieved by mechanical endovascular treatment for patients with large vessel occlusions. Complicating treatment-related symptomatic intracerebral hemorrhage and prolonged needle-to-recanalization times have been identified as major determinants of poor three-month functional outcomes. A hybrid mechanical-thrombolytic system with a patch imbued with an ultra-low dose of thrombolytic agents loaded onto a stent-retriever has been developed.

Methods

In this study, the in situ dose–response relationship of the thrombolytic patch imbued with up to 1000 IU of urokinase plasminogen activator (uPA) was quantified using Raman spectroscopy.

Results

Thrombi of up to 400 μm thickness dissolved within 15 min when patches imbued with < 1% of the conventional thrombolysis therapy dosage were applied. The results demonstrated that low-dose thrombolytic patches can dissolve normal clots compressed in the blood vessel in a short time. 500 IU is the threshold uPA dosage in the thrombolytic patch that most effectively dissolves the clots.

Conclusion

This study suggests that a novel endovascular stent-retriever loaded with an ultra-low drug dose fibrinolytic patch may be a suitable treatment for patients who are ineligible for conventional thrombolytic therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Adeoye, O., R. Hornung, P. Khatri, and D. Kleindorfer. Recombinant tissue-type plasminogen activator use for ischemic stroke in the united states a doubling of treatment rates over the course of 5 years. Stroke 42:1952–1955, 2011.

    Article  Google Scholar 

  2. Alexandrov, A. V., and J. C. Grotta. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 59:862–867, 2002.

    Article  Google Scholar 

  3. Ali, N. S., J. M. Akudugu, and R. W. Howell. A preliminary study on treatment of human breast cancer xenografts with a cocktail of paclitaxel, doxorubicin, and 131I-anti-epithelial cell adhesion molecule (9C4). World J. Nucl. Med. 18:18, 2019.

    Article  Google Scholar 

  4. Anderson, C. S., T. Robinson, R. I. Lindley, H. Arima, P. M. Lavados, T.-H. Lee, J. P. Broderick, X. Chen, G. Chen, and V. K. Sharma. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N. Engl. J. Med. 374:2313–2323, 2016.

    Article  Google Scholar 

  5. Andersson, T., M. Wiesmann, O. Nikoubashman, A. Gopinathan, P. Bhogal, and L. L. Yeo. The aspirations of direct aspiration for thrombectomy in ischemic stroke: a critical analysis. J. Stroke 21:2–9, 2019.

    Article  Google Scholar 

  6. Balami, J., P. White, P. McMeekin, G. Ford, and A. Buchan. Complications of endovascular treatment for acute ischemic stroke. Int. J. Stroke 13(4):348–361, 2017.

    Article  Google Scholar 

  7. Balami, J. S., G. Hadley, B. A. Sutherland, H. Karbalai, and A. M. Buchan. The exact science of stroke thrombolysis and the quiet art of patient selection. Brain 136:3528–3553, 2013.

    Article  Google Scholar 

  8. Boyd, S., M. F. Bertino, D. Ye, L. S. White, and S. J. Seashols. Highly sensitive detection of blood by surface enhanced Raman scattering. J. Forensic Sci. 58:753–756, 2013.

    Article  Google Scholar 

  9. Brunser, A. M., S. Illanes, P. M. Lavados, P. Muñoz, D. Cárcamo, A. Hoppe, V. V. Olavarria, I. Delgado, and V. Díaz. Exclusion criteria for intravenous thrombolysis in stroke mimics: an observational study. J. Stroke Cerebrovasc. Dis. 22:1140–1145, 2013.

    Article  Google Scholar 

  10. Chang, K.-C., S.-W. Hsu, C.-W. Liou, Y.-C. Huang, L.-H. Lee, C.-C. Lui, and Y.-L. Kuo. Intra-arterial thrombolytic therapy for acute intracranial large artery occlusive disease in patients selected by magnetic resonance image. J. Neurol. Sci. 297:46–51, 2010.

    Article  Google Scholar 

  11. Dargazanli, C., R. Fahed, R. Blanc, B. Gory, J. Labreuche, A. Duhamel, G. Marnat, S. Saleme, V. Costalat, and S. Bracard. Modified thrombolysis in cerebral infarction 2c/thrombolysis in cerebral infarction 3 reperfusion should be the aim of mechanical thrombectomy: insights from the ASTER Trial (Contact Aspiration Versus Stent Retriever for Successful Revascularization). Stroke 49:1189–1196, 2018.

    Article  Google Scholar 

  12. Demaerschalk, B. M., D. O. Kleindorfer, O. M. Adeoye, A. M. Demchuk, J. E. Fugate, J. C. Grotta, A. A. Khalessi, E. I. Levy, Y. Y. Palesch, and S. Prabhakaran. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 47:581–641, 2016.

    Article  Google Scholar 

  13. Diamond, S. L., and S. Anand. Inner clot diffusion and permeation during fibrinolysis. Biophys. J . 65:2622–2643, 1993.

    Article  Google Scholar 

  14. Diedler, J., N. Ahmed, M. Sykora, M. Uyttenboogaart, K. Overgaard, G.-J. Luijckx, L. Soinne, G. A. Ford, K. R. Lees, and N. Wahlgren. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset. Stroke 41:288–294, 2010.

    Article  Google Scholar 

  15. Dirks, M., L. W. Niessen, P. J. Koudstaal, C. L. Franke, R. J. van Oostenbrugge, and D. W. Dippel. Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delphi study. J. Neurol. Neurosurg. Psychiatry 78:685–689, 2007.

    Article  Google Scholar 

  16. Fransen, P. S., D. Beumer, O. A. Berkhemer, L. A. van den Berg, H. Lingsma, A. van der Lugt, W. H. van Zwam, R. J. van Oostenbrugge, Y. B. Roos, and C. B. Majoie. MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial. Trials 15:1, 2014.

    Article  Google Scholar 

  17. Gariel, F., B. Lapergue, R. Bourcier, J. Berge, X. Barreau, M. Mazighi, M. Kyheng, J. Labreuche, R. Fahed, and R. Blanc. Mechanical thrombectomy outcomes with or without intravenous thrombolysis: insight from the ASTER randomized trial. Stroke 49:2383–2390, 2018.

    Article  Google Scholar 

  18. Gory, B., B. Lapergue, R. Blanc, J. Labreuche, M. Ben Machaa, A. Duhamel, G. Marnat, S. Saleme, V. Costalat, and S. Bracard. Contact aspiration versus stent retriever in patients with acute ischemic stroke with M2 occlusion in the ASTER randomized trial (contact aspiration versus stent retriever for successful revascularization). Stroke 49:461–464, 2018.

    Article  Google Scholar 

  19. Hacke, W., P. Lyden, J. Emberson, C. Baigent, L. Blackwell, G. Albers, E. Bluhmki, T. Brott, G. Cohen, and S. M. Davis. Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: individual-patient-data meta-analysis of randomized trials. Int. J. Stroke 13:175–189, 2018.

    Article  Google Scholar 

  20. Jain, R., D. Calderon, P. R. Kierski, M. J. Schurr, C. J. Czuprynski, C. J. Murphy, J. F. McAnulty, and N. L. Abbott. Raman spectroscopy enables noninvasive biochemical characterization and identification of the stage of healing of a wound. Anal. Chem. 86:3764–3772, 2014.

    Article  Google Scholar 

  21. Jansen, I. G., M. J. Mulder, and R.-J. B. Goldhoorn. Endovascular treatment for acute ischaemic stroke in routine clinical practice: prospective, observational cohort study (MR CLEAN Registry). bmj 360:k949, 2018.

    Article  Google Scholar 

  22. Janssen, H., H. Brückmann, M. Killer, S. Heck, G. Buchholz, and J. Lutz. Acute basilar thrombosis: Recanalization following intravenous thrombolysis is dependent on thrombus length. PLoS ONE 13:2018.

    Article  Google Scholar 

  23. Kang, D.-H., Y.-H. Hwang, Y.-S. Kim, J. Park, O. Kwon, and C. Jung. Direct thrombus retrieval using the reperfusion catheter of the penumbra system: forced-suction thrombectomy in acute ischemic stroke. Am. J. Neuroradiol. 32:283–287, 2011.

    Article  Google Scholar 

  24. Kuoppala, M., J. Åkeson, P. Svensson, B. Lindblad, S. Franzen, and S. Acosta. Risk factors for haemorrhage during local intra-arterial thrombolysis for lower limb ischaemia. J. Thromb. Thrombolysis 31:226–232, 2011.

    Article  Google Scholar 

  25. Kwok, J. C. K., W. Huang, W.-C. Leung, S.-K. Chan, K.-Y. Chan, K.-M. Leung, A. C. H. Chu, and A. K. N. Lam. Human placenta as an ex vivo vascular model for neurointerventional research. J. Neurointervent. Surg. 6:394, 2013.

    Article  Google Scholar 

  26. la Rosa F. d. l. R., J. Khoury, B. M. Kissela, M. L. Flaherty, K. Alwell, C. J. Moomaw, P. Khatri, O. Adeoye, D. Woo, and S. Ferioli. Eligibility for intravenous recombinant tissue-type plasminogen activator within a population. The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial. Stroke 43:1591–1595, 2012.

  27. Lapergue, B., R. Blanc, B. Gory, J. Labreuche, A. Duhamel, G. Marnat, S. Saleme, V. Costalat, S. Bracard, and H. Desal. Effect of endovascular contact aspiration vs stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion: the ASTER randomized clinical trial. JAMA 318:443–452, 2017.

    Article  Google Scholar 

  28. Lefebvre, P., and I. Cohen. Effects of platelets and plasma on fibrinolysis. Blood Coag. Fibrinol. 3:237–242, 1992.

    Article  Google Scholar 

  29. Levine S. R., E. C. Haley, and P. D. Lyden. Pilot and preliminary studies of thrombolytic therapy for stroke. In: Thrombolytic Therapy for Acute Stroke. Springer, 2015, pp. 81–94.

  30. Levine, S. R., P. Khatri, J. P. Broderick, J. C. Grotta, S. E. Kasner, D. Kim, B. C. Meyer, P. Panagos, J. Romano, and P. Scott. Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria part 1: rapidly improving stroke symptoms. Stroke 44:2500–2505, 2013.

    Article  Google Scholar 

  31. McNamara, T. Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase. Am. J. Roentgenol. 144:769–775, 1985.

    Article  Google Scholar 

  32. Mocco, J., O. O. Zaidat, R. Von Kummer, A. J. Yoo, R. Gupta, D. Lopes, D. Frei, H. Shownkeen, R. Budzik, and Z. A. Ajani. Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke 47:2331–2338, 2016.

    Article  Google Scholar 

  33. Moussaddy, A., A. M. Demchuk, and M. D. Hill. Thrombolytic therapies for ischemic stroke: triumphs and future challenges. Neuropharmacology 134:272–279, 2018.

    Article  Google Scholar 

  34. Movasaghi, Z., S. Rehman, and I. U. Rehman. Raman spectroscopy of biological tissues. Appl. Spectrosc. Rev. 42:493–541, 2007.

    Article  Google Scholar 

  35. Mulder, M. J., I. G. Jansen, R.-J. B. Goldhoorn, E. Venema, V. Chalos, K. C. Compagne, B. Roozenbeek, H. F. Lingsma, W. J. Schonewille, and I. R. Van Den Wijngaard. Time to endovascular treatment and outcome in acute ischemic stroke: MR CLEAN Registry results. Circulation 138:232–240, 2018.

    Article  Google Scholar 

  36. Nam, J., H. Jing, and D. O’Reilly. Intra-arterial thrombolysis vs. standard treatment or intravenous thrombolysis in adults with acute ischemic stroke: a systematic review and meta-analysis. Int. J. Stroke 10:13–22, 2015.

    Article  Google Scholar 

  37. Powers, W. J., A. A. Rabinstein, T. Ackerson, O. M. Adeoye, N. C. Bambakidis, K. Becker, J. Biller, M. Brown, B. M. Demaerschalk, and B. Hoh. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49:e46–e110, 2018.

    Article  Google Scholar 

  38. Preissner, S., M. Dunkel, M. F. Hoffmann, S. C. Preissner, N. Genov, W. W. Rong, R. Preissner, and K. Seeger. Drug cocktail optimization in chemotherapy of cancer. PLoS ONE 7:2012.

    Article  Google Scholar 

  39. Premasiri, W., J. Lee, and L. Ziegler. Surface-enhanced Raman scattering of whole human blood, blood plasma, and red blood cells: cellular processes and bioanalytical sensing. J. Phys. Chem. B 116:9376–9386, 2012.

    Article  Google Scholar 

  40. Primiani, C. T., A. C. Vicente, M. T. Brannick, A. S. Turk, J. Mocco, E. I. Levy, A. H. Siddiqui, and M. Mokin. Direct aspiration versus stent retriever thrombectomy for acute stroke: a systematic review and meta-analysis in 9127 patients. J. Stroke Cerebrovasc. Dis. 28(5):1329–1337, 2019.

    Article  Google Scholar 

  41. Qin Z., C. H. Chon, A. K. Lam, J. C. Kwok, M. M. Yuen, and D. C. Lam. Feasibility examination of isolated zonal thrombolysis using Raman spectroscopy. In: Engineering in Medicine and Biology Society (EMBC), 2015 37th Annual International Conference of the IEEEIEEE, 2015, pp. 1353–1356.

  42. Qin, Z., F. Ciucci, C. H. Chon, J. C. Kwok, and D. C. Lam. Model development and comparison of low hemorrhage-risk endoluminal patch thrombolytic treatment for ischemic stroke. Med. Eng. Phys. 61:32–40, 2018.

    Article  Google Scholar 

  43. Rha, J.-H., and J. L. Saver. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 38:967–973, 2007.

    Article  Google Scholar 

  44. Riedel, C. H., P. Zimmermann, U. Jensen-Kondering, R. Stingele, G. Deuschl, and O. Jansen. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 42:1775–1777, 2011.

    Article  Google Scholar 

  45. Robinson, T. G., X. Wang, H. Arima, P. M. Bath, L. Billot, J. P. Broderick, A. M. Demchuk, G. A. Donnan, J. S. Kim, and P. M. Lavados. Low-versus standard-dose alteplase in patients on prior antiplatelet therapy: the ENCHANTED trial (enhanced control of hypertension and thrombolysis stroke study). Stroke 48:1877–1883, 2017.

    Article  Google Scholar 

  46. Roth, C., D. Junk, P. Papanagiotou, A. Keuler, H. Körner, M. Schumacher, and W. Reith. A comparison of 2 stroke devices: the new Aperio clot-removal device and the solitaire AB/FR. Am. J. Neuroradiol. 33:1317–1320, 2012.

    Article  Google Scholar 

  47. Sikirzhytski, V., K. Virkler, and I. K. Lednev. Discriminant analysis of Raman spectra for body fluid identification for forensic purposes. Sensors 10:2869–2884, 2010.

    Article  Google Scholar 

  48. Sung, S.-F., and M.-C. Tseng. Code stroke: a mismatch between number of activation and number of thrombolysis. J. Formos. Med. Assoc. 113:442–446, 2014.

    Article  Google Scholar 

  49. Virkler, K., and I. K. Lednev. Raman spectroscopic signature of blood and its potential application to forensic body fluid identification. Anal. Bioanal. Chem. 396:525–534, 2010.

    Article  Google Scholar 

  50. Wahlgren, N., N. Ahmed, A. Dávalos, G. A. Ford, M. Grond, W. Hacke, M. G. Hennerici, M. Kaste, S. Kuelkens, and V. Larrue. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. The Lancet 369:275–282, 2007.

    Article  Google Scholar 

  51. Wardlaw, J., E. Berge, G. del Zoppo, and T. Yamaguchi. Thrombolysis for acute ischemic stroke. Stroke 35:2914–2915, 2004.

    Article  Google Scholar 

  52. Wenger, K., F. Nagl, M. Wagner, and J. Berkefeld. Improvement of stent retriever design and efficacy of mechanical thrombectomy in a flow model. Cardiovasc. Intervent. Radiol. 36:192–197, 2013.

    Article  Google Scholar 

  53. Yuan, Z., B. Wang, F. Li, J. Wang, J. Zhi, E. Luo, Z. Liu, and G. Zhao. Intravenous thrombolysis guided by a telemedicine consultation system for acute ischaemic stroke patients in China: the protocol of a multicentre historically controlled study. BMJ Open 5:2015.

    Article  Google Scholar 

  54. Zaidat, O. O., A. C. Castonguay, R. G. Nogueira, D. C. Haussen, J. D. English, S. R. Satti, J. Chen, H. Farid, C. Borders, and E. Veznedaroglu. TREVO stent-retriever mechanical thrombectomy for acute ischemic stroke secondary to large vessel occlusion registry. J. Neurointerv. Surg. 10:516–524, 2018.

    Article  Google Scholar 

  55. Zarrinkoob, L., K. Ambarki, A. Wåhlin, R. Birgander, A. Eklund, and J. Malm. Blood flow distribution in cerebral arteries. J. Cereb. Blood Flow Metab. 35:648–654, 2015.

    Article  Google Scholar 

Download references

Acknowledgments

We would like to thank the Kwong Wah Hospital for providing clinical support, and the Materials Characterization and Preparation Facility (MCPF) for providing technical support. This research was supported in part by a donation from Mr. Louis NG [Grant Number: PD-NHK17EG01].

Conflict of interest

There is a filed US provisional patent application (US 62172044) in this paper related to Zhen Qin, Chi Hang Chon, John Ching Kwong Kwok, and David C C Lam. Peter Yat Ming Woo declares that he has no conflicts of interest.

Ethical Standards

No human studies or animal studies were carried out by the authors for this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David C. C. Lam.

Additional information

Associate Editor Michael R. King oversaw the review of this article.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qin, Z., Chon, C.H., Kwok, J.C.K. et al. Dose–Response Relationship and Threshold Drug Dosage Identification for a Novel Hybrid Mechanical-Thrombolytic System with an Ultra-Low Dose Patch. Cel. Mol. Bioeng. 14, 627–637 (2021). https://doi.org/10.1007/s12195-021-00683-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12195-021-00683-y

Keywords

Navigation